Effects and complications of placement of motility coupling post in porous polyethylene orbital implants.
- Author:
Hong-guang CUI
1
;
Rong-rong HU
;
Hui-yan LI
;
Wei HAN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Biocompatible Materials; Eye, Artificial; adverse effects; Female; Granuloma; etiology; Humans; Infection; etiology; Male; Middle Aged; Movement; Orbital Implants; adverse effects; Polyethylene; Postoperative Complications; etiology
- From: Journal of Zhejiang University. Science. B 2008;9(6):464-469
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo investigate the effects and complications of primary and secondary placements of motility coupling post (MCP) in the unwrapped porous polyethylene orbital implant (PPOI) following enucleation.
METHODSWe investigated 198 patients who received PPOI implantation following the standard enucleation procedure in the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, from 2002 to 2004. These patients were subgrouped into PPOI-only patients (112 cases, received PPOI following enucleation), primary MCP patients (46 cases, received primary placement of MCP during PPOI operation), and secondary MCP patients (40 cases, received secondary placement of MCP 6 months after the initial surgery). Effects and complications among these three groups were compared.
RESULTSThe PPOI-only patients took shorter treatment course when compared with other two MCP groups (P<0.001), without significant difference noted between the two MCP groups. However, the two MCP groups had better prosthetic motility than PPOI-only group (P<0.001), without significant difference between the two MCP groups. In the early stage, 2 eyes in the PPOI-only group and 1 eye in the primary MCP group had PPOI infection. In PPOI-only group, 3 (2.68%) eyes had PPOI exposure, which occurred after fitting the prostheses; 4 eyes (8.70%) in primary MCP group and 1 eye (2.50%) in secondary MCP had PPOI exposure, which occurred before fitting the prostheses. After prosthesis was fit successfully, the excessive discharge and granuloma were 33.9% and 1.79% in PPOI group-only, 53.3% and 8.9% in primary MCP group, and 52.5% and 7.5% in secondary MCP group, respectively.
CONCLUSIONBoth primary and secondary placements of MCP into the PPOI following enucleation can help patients to obtain desirable prosthetic motility, but may be associated with more complications. The primary placement of MCP with skilled operation in selected patients is more recommendable than secondary placement.